Researchers have new hope for HIV vaccine
UC infectious disease expert is featured guest on WVXU
Carl Fichtenbaum, MD, vice chair for clinical research in internal medicine in the University of Cincinnati College of Medicine and renowned HIV expert, recently appeared on WVXU radio's Cincinnati Edition program to talk about the new hope of developing an HIV vaccine.
Though a vaccine is likely still years away, a new injection therapy given several times a year is a game changer, he said.
"HIV should be just a part of the same, general discussions we have about having a healthy lifetime. We don't do that enough. We need to do it more," Fichtenbaum said.
Listen to the full episode online.
Featured image at top of HIV cell: Courtesy of National Institutes of Health
Related Stories
Does the president's prescription drug site actually make medications affordable?
March 20, 2026
Local 12 turned to Erwin Erhardt, PhD, economics professor in UC’s Lindner College of Business for insights on direct-to-consumer drugs.
Fusion reactors may be key to uncovering dark matter
March 20, 2026
Popular Mechanics highlights a new study by University of Cincinnati physicist Jure Zupan that explains how fusion reactors might create subatomic particles associated with dark matter.
UC study reshapes understanding of interaction between organelles in animal cells
March 20, 2026
Research published in the journal Cell Reports led by the University of Cincinnati’s Jiajie Diao, PhD, reshapes the field’s fundamental understanding of lysosomal acidification.